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original article

A Multicenter Study of Clostridium difficile
Infection–Related Colectomy, 2000–2006
Amelia M. Kasper, MD;1 Humaa A. Nyazee, MPH;1 Deborah S. Yokoe, MD;2 Jeanmarie Mayer, MD;3
Julie E. Mangino, MD;4 Yosef M. Khan, MD;4 Bala Hota, MD;5 Victoria J. Fraser, MD;1
Erik R. Dubberke, MD;1 for the Centers for Disease Control
and Prevention Epicenters Program

objective. To assess Clostridium difficile infection (CDI)–related colectomy rates by CDI surveillance definitions and over time at
multiple healthcare facilities.
setting.

Five university-affiliated acute care hospitals in the United States.

design and methods. Cases of CDI and patients who underwent colectomy from July 2000 through June 2006 were identified from
5 US tertiary care centers. Monthly CDI-related colectomy rates were calculated as the number of CDI-related colectomies per 1,000 CDI
cases, and cases were categorized according to recommended surveillance definitions. Logistic regression was performed to evaluate risk
factors for CDI-related colectomy.
results. In total, 8,569 cases of CDI were identified, and 75 patients underwent CDI-related colectomy. The overall colectomy rate was
8.7 per 1,000 CDI cases. The CDI-related colectomy rate ranged from 0 to 23 per 1,000 CDI episodes across hospitals. The colectomy rate
for healthcare-facility-onset CDI was 4.3 per 1,000 CDI cases, and that for community-onset CDI was 16.5 per 1,000 CDI cases (P ! .05).
There were significantly more CDI-related colectomies at hospitals B and C (P ! .05).
conclusions. The overall CDI-related colectomy rate was low, and there was no significant change in the CDI-related colectomy rate
over time. Onset of disease outside the study hospital was an independent risk factor for colectomy.
Infect Control Hosp Epidemiol 2012;33(5):470-476

Clostridium difficile infection (CDI) is one of the most common healthcare-associated infections, causing significant
morbidity and mortality, increased healthcare costs, and prolonged hospital lengths of stay.1-3 Published reports indicate
that the incidence and severity of CDI are increasing.4-6 The
emergence of a hypervirulent epidemic strain and community-acquired disease in patients who were previously considered to be at low risk will likely place an even greater
burden on patients and the healthcare system.7-9
Subtotal colectomy with end ileostomy is the treatment of
choice for patients with fulminant CDI refractory to medical
therapy.10-15 Studies have identified a variety of factors associated with improved survival after CDI-related colectomy,
and colectomy performed earlier in the course of fulminant
colitis, before the patient becomes critically ill, is generally
associated with improved survival.10,11,13,15-18 Studies have reported colectomy rates for CDI from less than 1% to 3% of
CDI cases,9,11,14-20 and the rate of colectomies for severe disease

appears to be rising over time.21 These studies have been
limited to single centers or outbreak settings, so little is known
about overall temporal trends in colectomy rates in nonoutbreak settings. Furthermore, the relationship between the location of CDI symptom onset and the risk of colectomy for
CDI is unknown.
The objective of this study was to conduct a multicenter,
multiyear analysis of the incidence of colectomies for severe
CDI in a nonoutbreak setting. Colectomy cases were further
classified by the location of CDI onset, on the basis of published recommended surveillance definitions.

methods
Setting and Population
Five geographically diverse academic hospitals participating
in the Prevention Epicenters Program of the Centers for Disease Control and Prevention collected inpatient data from
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table 1. Definitions of Clostridium difficile Infection (CDI) According to Exposures
Type of CDI
HCF onset, HCF associated
Community onset, study-hospital associated

Community onset, non-study-hospital associated

Community onset, community associated
Indeterminate

Recurrent
Unknown
note.

Definition
Patient’s stool sample tested positive 148 hours after admission to study hospital
Patient’s stool sample tested positive ≤48 hours after admission, provided that
symptom onset was !4 weeks after the last discharge from a HCF and the most
recent discharge was from an Epicenter
Patient’s stool sample tested positive ≤48 hours after admission, provided that
symptom onset was !4 weeks after the last discharge from a HCF and the most
recent discharge was from a HCF other than an Epicenter
Patient’s stool sample tested positive ≤48 hours after admission, provided that 112
weeks have elapsed since the last discharge from a HCF
Patient’s exposure setting does not fit any of the other criteria (eg, positive stool
sample ≤48 hours after admission with HCF exposure 4–12 weeks prior to sample collection)
Patient’s stool sample tested positive ≤8 weeks after a prior positive stool sample
Patient’s exposure setting could not be determined because of lack of available data

HCF, healthcare facility.

July 1, 2000, through June 30, 2006. These hospitals were
Barnes-Jewish Hospital (Saint Louis, MO), Brigham and
Women’s Hospital (Boston, MA), the Ohio State University
Medical Center (Columbus, OH), Stroger Hospital of Cook
County (Chicago, IL), and University of Utah Hospital (Salt
Lake City, UT). Notably, a prior study found that the rates
of CDI were significantly different between the hospitals, but
there were no sustained outbreaks.4 Inpatients 18 years old
or greater were included in the study. Electronic medical records were queried to retrospectively collect dates of positive
C. difficile toxin assay results; demographic information; comorbid conditions; International Classification of Diseases,
Ninth Revision, Clinical Modification (ICD-9-CM) diagnosis
codes; ICD-9-CM procedure codes for colectomy or hemicolectomy (45.73, 45.75, 45.76, 45.79, and 45.8); and admission and discharge dates. To provide a description of the
overall population at the 5 hospitals, 4 patients not diagnosed
with CDI were randomly selected among the patients discharged from the same study hospital during the same year
for every case of CDI identified by toxin assay results or ICD9-CM codes.
Definitions
The charts of all patients with a positive assay for C. difficile
or the ICD-9-CM diagnosis code for CDI and an ICD-9-CM
procedure code for colectomy were reviewed to determine if
the colectomy was for CDI (CDI-related colectomy). For patients without a colectomy, a case of CDI was defined as a
positive C. difficile stool toxin assay. For patients with CDIrelated colectomy, a case of CDI was defined as the presence
of a positive C. difficile toxin assay or the presence of the
ICD-9-CM code for CDI and a CDI-related colectomy. The
reason to have different definitions for a case of CDI based
on whether there was a colectomy for CDI is 2-fold. All study
hospitals are academic medical centers. Patients may be transferred for severe CDI and proceed to colectomy without repeating a toxin assay. In addition, patients with fulminant

CDI may have an ileus or be taken to surgery prior to procurement of stool for C. difficile testing. Therefore, it was
determined that the charts of patients assigned the ICD-9CM code for CDI and a procedure code for colectomy would
be reviewed. Conversely, most patients assigned the ICD-9CM code for CDI without a positive toxin assay do not have
CDI on the basis of further chart review.22 Because of this,
it was determined to be unnecessary to review the charts of
the approximately 3,000 patients who were assigned the ICD9-CM code for CDI but who did not have a positive toxin
assay or a colectomy.
Cases of CDI were categorized on the basis of published
surveillance definitions.4,23-25 Charts of all patients with CDI
onset 48 hours or less from admission were reviewed to determine recent healthcare exposures. Cases were categorized
as healthcare facility (HCF) onset; community onset, studyhospital associated; community onset, non-study-hospital associated; indeterminate; and recurrent (Table 1). Recurrent
cases were cases of CDI with a history of a positive toxin
assay within the previous 8 weeks.
Data Analysis
Colectomy rates were calculated as the number of CDI-related
colectomies per 1,000 toxin-positive cases. Data from hospital
E were incomplete for the first 14 months; these months for
hospital E were excluded from the analysis. Composite Charlson scores were calculated to assess comorbidity.26 All tests
were 2-tailed, and a P value of less than .05 was considered
statistically significant, with Bonferroni adjustments for multiple comparisons when applicable. Data were compared with
x2, x2 for trend, Fisher exact, and Mann-Whitney U tests.
Univariate logistic regression was used to examine the contributions of age, sex, race, location of onset, Charlson score,
and study center to the risk of colectomy. Variables associated
with colectomy in unadjusted analysis (P ! .05) were included
in a multivariable regression logistic model to identify independent predictors of colectomy. Stepwise backward lo-
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table 2. Patient Characteristics
Hospital, characteristic
Hospital A (n p 28,215)
No. of patients
Age, median (range), years
Female, no. (%)
Nonwhite, no. (%)
Charlson score, mean (range)
Mortality
Hospital B (n p 8,313)
No. of patients
Age, median (range), years
Female, no. (%)
Nonwhite, no. (%)
Charlson score, mean (range)
Mortality, %
Hospital C (n p 10,692)
No. of patients
Age, median (range), years
Female, no. (%)
Nonwhite, no. (%)
Charlson score, mean (range)
Mortality, %
Hospital D (n p 10,201)
No. of patients
Age, median (range), years
Female, no. (%)
Nonwhite, no. (%)
Charlson score, mean (range)
Mortality, %
Hospital E (n p 4,165)
No. of patients
Age, median (range), years
Female, no. (%)
Nonwhite, no. (%)
Charlson score, mean (range)
Mortality, %
Overall (n p 61,586)
No. of patients
Age, median (range), years
Female, no. (%)
Nonwhite, no. (%)
Charlson score, mean (range)
Mortality, %

Patients without CDI

Patients with CDIa

Patients with
colectomy for CDI

24,232
55.1
13,727
9,075
1.5
2.8

(18–103)
(57)
(37)
(0–16)

3,955
64.1
2,015
1,192
2.2
12.7

(18–105)
(51)
(30)
(0–15)

28
68.1
15
7
1.4
53.6

(23–87)
(54)
(25)
(0–7)

6,977
47.1
4,016
1,315
1.1
2.2

(18–101)
(58)
(19)
(0–12)

1,332
56.2
662
168
2.2
6.5

(18–102)
(50)
(13)
(0–14)

4
42.2
0
0
1.3
25.0

(36–66)
(0)
(0)
(0–4)

9,641
54.3
5,612
2,643
1.6
3.3

(18–106)
(58)
(27)
(0–15)

1,026
65.6
535
166
2.5
8.4

(18–97)
(52)
(16)
(0–14)

25
69.6
11
4
2.2
28.0

(42–87)
(44)
(16)
(0–11)

9,147
53.9
5,266
3,153
1.3
2.4

(18–104)
(58)
(34)
(0–15)

1,036
63.4
512
231
1.4
8.6

(19–100)
(49)
(22)
(0–11)

18
70.1
6
2
0.6
33.3

(44–88)
(33)
(11)
(0–3)

3,530
49.9
1,691
3,139
0.5
2.4

(18–100)
(48)
(89)
(0–10)

635
50.6
237
552
0.7
7.7

(18–99)
(37)
(87)
(0–11)

53,527
53.4
30,312
19,325
1.4
2.7

(18–106)
(57)
(36)
(0–16)

7,984
61.5
3,961
2,309
2.0
10.2

(18–105)b
(50)
(29)
(0–15)d

0
...
...
...
...
...
75
68.2
32
13
1.5
38.7

(23–88)c
(43)
(17)
(0–11)e

note. CDI, Clostridium difficile infection.
a
Cases of recurrent CDI are excluded.
b
P ! .05 comparing age of patients with and without CDI.
c
P p .03 comparing age of patients with CDI with and without colectomy.
d
P ! .05 comparing Charlson score of patients with and without CDI.
e
P p .04 comparing Charlson score of patients with CDI with and without colectomy.

gistic regression was used for multivariate analysis. Variables
with significance levels of P less than .05 were retained in the
final model. Odds ratios (ORs) with 95% confidence intervals
(CIs) were calculated for each variable. Data were analyzed
using Epi Info, version 3.4 (Centers for Disease Control and
Prevention, Atlanta, GA), and SPSS for Windows, version
17.0 (SPSS, Chicago, IL). Approval was obtained from the

institutional review boards of the Centers for Disease Control
and Prevention and each of the participating centers.

results
During the study period, there were 8,569 episodes of toxinpositive CDI among 8,033 patients, including 540 (6.3%)

colectomy rates for cdi, 2000–2006

figure 1. Colectomy rates by hospital over time. There was a significant increase in colectomies over time at hospital A (P p .01).
CDI, Clostridium difficile infection.

cases of recurrent CDI. There were 252 patients who had a
positive toxin assay or who were assigned the ICD-9-CM code
for CDI and underwent a colectomy during the same hospitalization. Seventy-five (29.8%) of these patients had a CDIrelated colectomy. Forty-nine patients (65%) with CDIrelated colectomy had a documented positive toxin assay
during the same admission. The colectomy incidence over
the entire study period was 8.7 CDI-related colectomies per
1,000 CDI episodes. There was no significant overall trend
in the annual incidence of CDI-related colectomy during the
study period.
Demographic data are provided in Table 2. Overall, patients
with CDI were older (P ! .05) and had higher Charlson scores
than patients without CDI (P ! .05 ). The median age of patients who had a CDI-related colectomy was higher than that
of patients with CDI who did not have a colectomy (68.2 vs
61.5 years; P p .03). White patients made up 71% of toxinpositive CDI cases but 83% of patients who had a CDI-related
colectomy (P p .03). The proportion of colectomy patients
who were female was 43%, compared with 50% of patients
with a CDI-related colectomy (P p .23). The population of
patients who underwent a CDI-related colectomy had lower

Charlson scores than patients with CDI who did not undergo
colectomy (P p .04).
Colectomy incidence at each hospital during the study period ranged from 0 to 23 per 1,000 CDI episodes. The only
hospital with a significant linear trend in the annual colectomy rate over time was hospital A, which had an increase
in CDI-related colectomy during the study period (P p .01;
Figure 1). Though annual variations were evident, particularly
at hospitals C and D, there were likely too few colectomies
to find a significant linear trend. No colectomies for CDI
were reported at hospital E during the study period. Comparisons by study center are presented in Table 2. Among
patients without CDI, those at hospital A were the oldest,
and those at hospital B were the youngest (55 vs 47 years;
P ! .001). Patients at hospital C had the highest Charlson
comorbidity scores, and those at hospital E had the lowest
(1.6 vs 0.5; P ! .001). Among patients with CDI who did not
undergo colectomy, those at hospital C were the oldest (66
years) and had the highest Charlson scores (2.5), whereas
those at hospital E were the youngest (51 years) and had the
lowest Charlson scores (0.7; both P ! .001). Patients with
CDI-related colectomy were the oldest (70 years) at hospital
D and the youngest at hospital B (42 years; P p .02, not
significant after Bonferroni correction). Those who had CDIrelated colectomy at hospital D had the lowest Charlson
scores, and those at hospital C had the highest scores (0.6 vs
2.2; P p .01).
HCF-onset CDI represented 4,897 episodes of CDI (58% of
all toxin-positive episodes; Table 3). There were 21 CDI-related
colectomies for HCF-onset CDI, accounting for 29% of all
CDI-related colectomies. There were 794 episodes of community-onset, study-hospital-associated CDI (9% of all episodes) and 10 CDI-related colectomies (13% of CDI-related
colectomy). The community-onset, non-study-hospital-associated category included 1,063 episodes of CDI (12% of all
episodes) and 23 CDI-related colectomies (31% of CDI-related
colectomies). There were 520 episodes of community-associated CDI (6% of all episodes) and 5 CDI-related colectomies
(7% of CDI-related colectomies). Community-onset cases had
higher colectomy rates than hospital-onset cases at all 4 hospitals that reported colectomies during the study period (Figure

table 3. Comparison of Clostridium difficile Infection (CDI) Incidence and Deaths by Surveillance Definitions
Patients with
CDI, no colectomy
No. (%)
of patients
Hospital onset
Community onset, study-hospital associated
Community onset, non-study-hospital associated
Indeterminate
Community associated
Recurrent
Unknown

4,897
794
1,063
365
520
536
345

(57.5)
(9.3)
(12.5)
(4.3)
(6.1)
(6.3)
(4.0)
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Patients with
colectomy for CDI

No. (%)
of deaths

No. (%)
of patients

No. (%)
of deaths

554
70
113
20
26
71
19

21
10
23
8
5
3
5

10
4
8
3
0
3
1

(11.3)
(8.8)
(10.6)
(5.5)
(5.0)
(13.2)
(5.5)

(28.8)
(10.7)
(30.7)
(10.7)
(6.7)
(4)
(6.7)

(47.6)
(80)
(80)
(37.5)
(0)
(100)
(38.7)

Colectomies for CDI
per 1,000 cases
4.3
12.4
21.2
21.4
9.5
5.6
14.3
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figure 2. Clostridium difficile infection (CDI)–related colectomy
rates by location of symptom onset. HCF, healthcare facility.

2). Six percent of cases and 4% of colectomies occurred among
patients with recurrent CDI.
Risk factors for CDI-related colectomy are presented in
Table 4. Advanced age (65 years and older) was associated
with colectomy, with an OR of 1.9 (P ! .05). White patients
had a significantly higher OR for colectomy than nonwhite
patients (OR, 2.0; P p .02). Admission to hospitals C and D
was also associated with more CDI-related colectomies
(P ! .05). There were no differences in the risk of colectomy
by patient gender, discharge year, or Charlson score. After
multivariable adjustment, age of 65 years or older (OR, 1.6
[95% CI, 1.0–2.6]), admission to hospital C (OR, 4.0 [95%
CI, 2.3–7.0]) or D (OR, 2.4 [95% CI, 1.3–4.5]), and community-onset CDI (OR, 3.4 [95% CI, 2.0–5.5]) remained
significantly associated with CDI-related colectomy.

discussion
This study examined CDI-related colectomy rates at multiple
HCFs over a 6-year period. We also assessed risk factors associated with CDI-related colectomy. Prior studies of colectomy for CDI have been limited by being conducted at single
centers, over relatively brief periods of time, or in response
to CDI outbreaks. These studies have potentially biased the
literature to more severe outbreaks of CDI. Our study minimizes these biases by including multiple HCFs over several
years in the absence of any sudden increases in CDI incidence
or clinically apparent increases in deaths due to CDI.4
CDI-related colectomy rates in the literature differ based
on the clinical setting, drawing from a wide variety of patient
populations and CDI rates. The overall CDI-related colectomy rate in this study was 8.7 per 1,000 CDI cases, consistent
with previously published rates, which ranged from 2.7 to 32
colectomies per 1,000 CDI cases.9,11,14-20 Kutty et al9 recently
published a report of a community-based CDI outbreak in

6 hospitals in North Carolina involving 109 patients with
CDI; none required intensive care unit admission or a colectomy. It was hypothesized that the paucity of severe cases
was due to the young age of the study population (median,
62 years). In contrast, Lamontagne et al13 found that 23% of
the 165 patients in 2 hospitals’ intensive care units with fulminant colitis required a colectomy. The hospitalized population in our study includes low- and high-acuity patients,
and the colectomy rate fell between those 2 extremes.
There are few published data describing colectomy rates
according to CDI surveillance definitions. One single-center
study during an outbreak at a community hospital reported
a colectomy incidence for HCF-onset CDI of 2%.19 The HCFonset colectomy rate in our study was lower, at 0.43%. We
found that patients who had community-onset CDI with recent HCF exposure had the highest colectomy rate (Table 3).
To our knowledge, there are no prior studies of colectomy
incidence among community-onset cases that can be used
for comparison. The colectomy rate among patients with
community-onset CDI in this study may be biased high. Four
of the 5 study hospitals are academic referral centers. It is
not uncommon for patients with severe CDI to be transferred
for management of severe CDI and possible colectomy.
There are no standard guidelines for selecting patients with
CDI for colectomy, and this may account for the differences
in CDI-related colectomy rates across the study hospitals.
Some patterns did emerge. Overall, patients who underwent
CDI-related colectomy were significantly older than patients
with CDI who did not have a colectomy. This age difference
was present at all centers and likely reflects the higher likelihood of older patients developing severe CDI.6,20,27 Patients
who had a CDI-related colectomy had lower Charlson scores
than patients with CDI who did not have a colectomy. This
may reflect a greater willingness to proceed to colectomy
among patients with fewer comorbidities, who are more likely
to survive an emergent, high-risk procedure. Patients were
more likely to have a colectomy for CDI at hospitals C and
D. At these particular centers, there were no obvious associations between mortality of patients without CDI and either
mortality of patients with CDI or CDI-related colectomy
rates. Data on treatment for CDI was not collected. Therefore,
it is not possible to determine whether differences in CDIrelated colectomy rates translated to improved patient
outcomes.
This study has some limitations. Different case definitions
were used for the numerator and denominator to determine
the rate of CDI-related colectomy. When conducting surveillance for a rare event, missing a few cases may result in
large differences in the identified disease incidence. On the
other hand, missing a few noncases has less of an impact on
the identified disease incidence. These factors must be considered when balancing the accuracy of the method of surveillance with the resources necessary to conduct the surveillance. Use of ICD-9-CM codes to identify patients with
CDI has been shown to overestimate the number of cases of
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table 4. Factors Associated with Clostridium difficile Infection (CDI)–Related Colectomy
Characteristic
Age
18–64 years
≥65 years
Sex
Female
Male
Race
Nonwhite
White
Charlson score
0–1
2–3
4–5
≥6
Surveillance definition
HCF onset
Community onset
Discharge year
2000–2001
2001–2002
2002–2003
2003–2004
2004–2005
2005–2006
Study hospitala
A
B
C
D

Colectomies for CDI
per 1,000 patients

OR (95% CI)

P

Multivariable OR
(95% CI)

Multivariable P

6.2
12.1

1.0 (reference)
1.9 (1.2–3.2)

!.05

1.0 (reference)
1.6 (1.0–2.6)

.05

7.6
10.0

1.0 (reference)
1.3 (0.8–2.1)

.2

1.0 (reference)
1.4 (0.9–2.3)

.15

5.3
10.3

1.0 (reference)
2.0 (1.1–3.8)

.02

1.0 (reference)
1.6 (0.8–2.9)

.16

10.4
8.8
2.2
4.3

1.0
0.9
0.2
0.4

.5
.1
.1

...
...
...
...

4.3
16.5

1.0 (reference)
3.9 (2.3–6.8)

!.05

1.0 (reference)
3.4 (2.0–5.5)

9.4
6.0
7.8
7.7
7.4
12.8

1.0
0.6
0.8
0.8
0.8
1.4

(reference)
(0.2–1.9)
(0.3–2.2)
(0.3–2.2)
(0.3–2.0)
(0.6–3.2)

.4
.7
.7
.6
.4

...
...
...
...
...
...

6.4
3.0
23.1
16.2

1.0
0.5
3.6
2.5

(reference)
(0.1–1.4)
(2.0–6.4)
(1.3–4.7)

.1
!.05
!.05

(reference)
(0.5–1.4)
(0–2.9)
(0.2–1.2)

1.0
0.6
4.0
2.4

(reference)
(0.2–1.6)
(2.3–7.0)
(1.3–4.5)

!.05

.27
!.05
!.05

note. Boldface type indicates statistical significance. CI, confidence interval; HCF, healthcare facility; OR, odds ratio.
a
Hospital E was not included in this analysis because there were no colectomies for CDI reported during the study period.

CDI, and most patients with the ICD-9-CM code for CDI
but without a corresponding positive toxin assay do not have
CDI. Although ICD-9-CM codes are specific for CDI, the
positive predictive value is only approximately 75% because
of the relatively low prevalence of CDI.22 Therefore, it was
decided to limit the CDI-without-colectomy group to CDI
cases with positive toxin assays only. Conversely, there was
concern that some patients with CDI diagnosed at a referring
HCF would be transferred for severe CDI and proceed to
colectomy without repeating a toxin assay at the study hospital or that patients with fulminant CDI may be taken to
surgery prior to procurement of a stool specimen for toxin
testing. Although these cases represent a minority of all CDI
cases, they may represent a large proportion of patients who
undergo a CDI-related colectomy. These patients were included in the definition of CDI-related colectomy to avoid
missing these cases. Consequently, colectomy rates may be
overestimated, particularly for community-onset, non-studyhospital-associated cases. This is notable considering the overall low incidence of colectomy identified in this study.
As reported previously,4 hospital B experienced a CDI
pseudo-outbreak from July 1, 2004, to June 30, 2006, related
to improper stool sample collection and transport. We chose

to include data from hospital B during the pseudo-outbreak
for this particular study, since 2 of the 4 colectomies performed during the study period at hospital B were performed
during the pseudo-outbreak. The true colectomy incidence
during these periods is therefore likely biased low. Another
limitation of the data is that different toxin assays were used
among the hospitals over the study period. It is unclear how
or to what extent these different assays may have influenced
CDI incidence. Additionally, data on infecting C. difficile
strains are not available. It is possible that the hospitals involved in this study have a low proportion of CDI cases due
to highly virulent epidemic strains, thus accounting for the
low colectomy incidence. The epidemic BI/NAP1/027 strain
has been identified at hospital A.
This study reports that no significant change in overall
colectomy rates occurred from 2000 to 2006 but that CDIrelated colectomy is associated with community-onset CDI,
there are differences in colectomy incidence across HCFs
without an obvious impact on outcome, and CDI-related
colectomy is associated with high mortality. Because of the
difficulties in establishing optimal criteria on when to take a
patient with CDI to surgery, our study supports the need for
prospective surveillance studies to track CDI-related colec-
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tomy trends in stable sentinel populations while using standardized case definitions. Studies such as these will allow for
comparisons between HCFs to identify trends in CDI-related
colectomies and factors associated with improved patient outcomes, which can be used to improve patient selection for
CDI-related colectomy.
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